| Ž–¼ | ‚è@—mŽO |
|---|---|
| ƒ[ƒ}Žš–¼ | Takasaki Yozo |
| ¶”NŒŽ“ú | 1945.6.24 |
| Š‘®E–¼ | ‹³Žö |
| Šw—ð | “Œ‹ž‘åŠw‹³—{Šw•”Šî‘b‰ÈŠw‰È‘² (1968.3) |
| “Œ‹ž‘åŠw‘åŠw‰@—ŠwŒ¤‹†‰È‘ŠŠÖ—‰»Šwê–å‰Û’ö”ŽŽm‰Û’öC—¹(1973.3) | |
| ŠwˆÊ | —Šw”ŽŽm |
| Žå—vE—ð | 1973.4 ’élДޮ‰ïŽÐŽÐˆõ |
| 1977.5 ‹ãB‘åŠwˆãŠw•”•Žè | |
| 1978.4 ²‰êˆã‰È‘åŠw•‹³Žö | |
| 1994.6 ²‰êˆã‰È‘åŠw‹³Žö | |
| Žö‹Æ‰È–Ú | ×–E¶•¨Šw IAŠî‘bˆãŠw“Á˜_A‰»ŠwŽÀŒ±AŠî‘b‰»ŠwiŠw•”j |
| ¶‘̧ŒäŒnˆâ“`ŽqHŠwi‘åŠw‰@Œ¤‹†‰Èj | |
| ê–啪–ì | ¶‰»ŠwC’`”’HŠw |
| Œ¤‹†ƒe[ƒ} | §ŒÀy‘f HindIII ‚Ì\‘¢‚Ɗ“ÁˆÙ«‚ÌŠÖŒW |
| ƒL[ƒ[ƒh | §ŒÀy‘fCHindIIICSite-dircted mutagenesisCŠîŽ¿“ÁˆÙ«CHis-tag proteinCŒ‹»‰»CƒVƒ“ƒNƒƒgƒƒ“•úŽËŒõ |
| Š‘®Šw‰ï | “ú–{¶‰»Šw‰ïi‘ã‹cˆõA•]‹cˆõj |
| “ú–{”_Œ|‰»Šw‰ï | |
| Žå—v˜_•¶ | ˆÙíˆâ“`Žq‚Ì”Œ»‚É‚æ‚é‰ðÍ@V¶‰»ŠwŽÀŒ±uÀ‚P‚TŠª, p 79-83, 1992 |
| Mutational analyses of restriction endonuclease __ HindIII mutant E86K with higher activity and altered specificity. Protein Engineering 13: 283-289, 2000 | |
| Two Forms of Restriction Enzyme HindIII. J. Biochem. 116: 1281-1286, 1994 | |
| Construction and properties of active chimeric enzyme between human aldolases A and B: analysis of molecular regions which determine isozyme-specific functions. J. Biol. Chem. 265: 17493-17498, 1990 | |
| Human Aldolase A of a Hemolytic Patient with Asp-Gly Substitution: Characteristics of an enzyme generated in E. coli transfected with the expression plasmid pHAAD128G. J. Biochem. 108: 153-157, 1990 | |
| vŒ£ƒe[ƒ} | V‚µ‚¢‹@”\‚ðŠl“¾‚µ‚½’`”’Ž¿‚Ì‘n¶C’`”’Ž¿‚Ì—§‘Ì\‘¢‚̉𖾠|
| ƒz[ƒ€ | http://www.ged.saga-med.ac.jp/ |
| ƒ[ƒ‹ | takasaky@post.saga-med.ac.jp |
| ‚e‚`‚w | 0952-34-2022 |